Cargando…
Adaptive Immunity in Ankylosing Spondylitis: Phenotype and Functional Alterations of T-Cells before and during Infliximab Therapy
Our aim was to assess the phenotype of T-cell subsets in patients with ankylosing spondylitis (AS), a chronic inflammatory rheumatic disease. In addition, we also tested short-term T-cell activation characteristics. Measurements were done in 13 AS patients before and during the intravenous therapy w...
Autores principales: | Szalay, Balázs, Mészáros, Gergő, Cseh, Áron, Ács, Lilla, Deák, Magdolna, Kovács, László, Vásárhelyi, Barna, Balog, Attila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182565/ https://www.ncbi.nlm.nih.gov/pubmed/21969839 http://dx.doi.org/10.1155/2012/808724 |
Ejemplares similares
-
The Impact of DMARD and Anti-TNF Therapy on Functional Characterization of Short-Term T-Cell Activation in Patients with Rheumatoid Arthritis – A Follow-Up Study
por: Szalay, Balázs, et al.
Publicado: (2014) -
Infliximab in the treatment of ankylosing spondylitis
por: Grainger, Rebecca, et al.
Publicado: (2007) -
Management of ankylosing spondylitis with infliximab
por: Toussirot, Éric, et al.
Publicado: (2009) -
Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab
por: Kim, Bo Young, et al.
Publicado: (2017) -
Pleural Tuberculosis following Infliximab Therapy for Ankylosing Spondylitis
por: Krishnan, V. S. Gokul, et al.
Publicado: (2017)